227 related articles for article (PubMed ID: 1459313)
1. Increased lipid peroxidation in type 2 poorly controlled diabetic patients.
Altomare E; Vendemiale G; Chicco D; Procacci V; Cirelli F
Diabete Metab; 1992; 18(4):264-71. PubMed ID: 1459313
[TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus.
Peerapatdit T; Likidlilid A; Patchanans N; Somkasetrin A
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S141-6. PubMed ID: 17718255
[TBL] [Abstract][Full Text] [Related]
5. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I
Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
[TBL] [Abstract][Full Text] [Related]
6. Plasma malondialdehyde levels and risk factors for the development of chronic complications in type 2 diabetic patients on insulin therapy.
Kaefer M; De Carvalho JA; Piva SJ; da Silva DB; Becker AM; Sangoi MB; Almeida TC; Hermes CL; Coelho AC; Tonello R; Moreira AP; Garcia SC; Moretto MB; Moresco RN
Clin Lab; 2012; 58(9-10):973-8. PubMed ID: 23163113
[TBL] [Abstract][Full Text] [Related]
7. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
8. Lipoproteins and lipid peroxidation abnormalities in patients with chronic renal disease.
Ong-Ajyooth L; Ong-Ajyooth S; Sirisalee K; Nilwarangkur S
J Med Assoc Thai; 1996 Aug; 79(8):505-12. PubMed ID: 8855633
[TBL] [Abstract][Full Text] [Related]
9. Plasma antioxidants and type 2 diabetes mellitus.
Palanduz S; Ademoğlu E; Gökkuşu C; Tamer S
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):309-18. PubMed ID: 12889514
[TBL] [Abstract][Full Text] [Related]
10. Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM.
Abdella N; al Awadi F; Salman A; Armstrong D
Diabetes Res; 1990 Dec; 15(4):173-7. PubMed ID: 2132405
[TBL] [Abstract][Full Text] [Related]
11. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels.
Yesilbursa D; Serdar Z; Serdar A; Sarac M; Coskun S; Jale C
Int J Obes (Lond); 2005 Jan; 29(1):142-5. PubMed ID: 15467775
[TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
13. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients.
Mahboob M; Rahman MF; Grover P
Singapore Med J; 2005 Jul; 46(7):322-4. PubMed ID: 15968442
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis.
Lamsal M; Gautam N; Bhatta N; Toora BD; Bhattacharya SK; Baral N
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):695-703. PubMed ID: 17883009
[TBL] [Abstract][Full Text] [Related]
15. Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study.
Davidson JA; Perez A; Zhang J;
Diabetes Obes Metab; 2006 Mar; 8(2):164-74. PubMed ID: 16448520
[TBL] [Abstract][Full Text] [Related]
16. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
Sarban S; Kocyigit A; Yazar M; Isikan UE
Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and catalase in diabetes mellitus with and without ischemic stroke.
Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M; Lazăr L; Drută A
Rom J Intern Med; 2004; 42(2):423-9. PubMed ID: 15529632
[TBL] [Abstract][Full Text] [Related]
18. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Hashim Z; Zarina S
Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
Rosenstock J; Einhorn D; Hershon K; Glazer NB; Yu S;
Int J Clin Pract; 2002 May; 56(4):251-7. PubMed ID: 12074206
[TBL] [Abstract][Full Text] [Related]
20. Oxidative protein damage in plasma of type 2 diabetic patients.
Telci A; Cakatay U; Kayali R; Erdoğan C; Orhan Y; Sivas A; Akçay T
Horm Metab Res; 2000 Jan; 32(1):40-3. PubMed ID: 10727013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
